Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 28, 2013
SEOM clinical guidelines for the systemic treatment of early breast cancer 2013S Del Barco, E Ciruelos, I Tusquets, et al.
Medicina Clinica|July 4, 1992
[Acquired immunodeficiency syndrome and T-cell non-Hodgkin's lymphoma]M Doménech, I Tusquets, X Fabregat, et al.
Cancer Treatment Reviews|July 17, 2012
Finding the right dose of fulvestrant in breast cancerL Estévez, I Alvarez, I Tusquets, et al.
Revista Clinica Espanola|April 1, 1990
[Yield of diagnostic tests in neoplasms of unknown origin. A retrospective study]M Gil Gil, C Vadell Nadal, X Fabregat Mayol, et al.
British Journal of Cancer|January 22, 2009
Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trialA Barnadas, M Gil, S González, et al.
Cancer|March 15, 1995
Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trialA Abad, P Garcia, C Gravalos, et al.
Breast Cancer Research and Treatment|October 23, 2008
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trialS Del Barco, R Colomer, L Calvo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1991
Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patientsM Beltrán, M C Alonso, M B Ojeda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancerL Cirera, A Balil, E Batiste-Alentorn, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domainR Colomer, A Llombart-Cussac, I Tusquets, et al.
Pageof 2